Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation.

Elena M Donald Elissa DrigginJason ChoeJaya BatraFabian VargasJordan LindekensJustin A FriedJayant K RaikhelkarDavid J BaeKyung T OhMelana YuzefpolskayaPaolo C ColomboFarhana LatifGabriel SayerNir UrielKevin D Clerkin Ersilia M DeFilippis

Published in: Clinical transplantation (2024)

HT recipients prescribed GLP1-RA therapy showed improved glycemic control, weight loss, and cholesterol levels during the study follow-up period. GLP1-RA were well tolerated and were rarely associated with changes in immunosuppression dosing.

Keyphrases

glycemic control
weight loss
type diabetes
rheumatoid arthritis
blood glucose
bariatric surgery
disease activity
roux en y gastric bypass
gastric bypass
ankylosing spondylitis
insulin resistance
metabolic syndrome
skeletal muscle
bone marrow
replacement therapy
smoking cessation